Release Date: 01/05/13 08:42 Summary: Quarterly Activities and Cashflow Report - March 2013 Price Sensitive: No Download Document 2.9MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%